Answer
Yes, sustained-release disopyramide phosphate is contraindicated in patients with renal or hepatic impairment.
Sources for this answer
- Disopyramide Neon 250 mg Prolonged-Release TabletsNeon Healthcare Ltd · emc · SmPC §4.3 Contraindications · Version 2Document updated
Sources checked